• Nie Znaleziono Wyników

Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension

N/A
N/A
Protected

Academic year: 2022

Share "Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension"

Copied!
1
0
0

Pełen tekst

(1)

www.kardiologiapolska.pl

Kardiologia Polska 2013; 71, 12: 1331; DOI: 10.5603/KP.2013.0343 ISSN 0022–9032

STUDIUM PRZYPADKU / CLINICAL VIGNETTE

Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension

Balonowa angioplastyka płucna u chorej z nieoperacyjnym przewlekłym zakrzepowo-zatorowym nadciśnieniem płucnym

Szymon Darocha

1

, Marcin Kurzyna

1

, Radosław Pietura

2

, Adam Torbicki

1

1Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, ECZ – Otwock, Poland

2Department of Radiography, Medical University of Lublin, Poland

A 43-year-old female had been diagnosed as having chronic thromboembolic pulmonary hypertension (CTEPH) two years previously with pulmonary artery (PA) thrombus detected by computed tomography (CT) (Fig. 1) and precapillary pulmo- nary hypertension (mean PA pressure [mPAP] 56 mm Hg, cardiac ouput [CO] 6.03 L/min, PA wedge pressure 8 mm Hg, pulmonary vascular resistance [PVR] 7.96 Wood units) by right heart catheterisation (RHC). She was referred to the cardiac surgeon and was not qualified for pulmonary endarterectomy. The patient was treated with sildenafil (off-label) for one year with no improvement. She was admitted to our institution in July 2013 presenting symptoms of class III NYHA heart failure. Echocardiography revealed the progression of right ventricular failure (Fig. 2). Selective pulmonary arteriography confirmed distal localisation of thrombi in segmental arteries of left lower lobe (Fig. 3). Balloon pulmonary angioplasty (BPA) of two segmental arteries was performed, resulting in an improvement in control angiography (Fig. 4). The next BPA of another two segmental arteries was performed after three months. There were no complications during or after the pro- cedures. Subsequent RHC

confirmed an improvement (mPAP 33 mm Hg , CO 4.88 L/min, PVR 4.50 Wood units). The patient presented clinical recovery and symp- toms of class II NYHA.

Pulmonary endarterectomy is the only potentially cura- tive treatment for CTEPH.

The prognosis of CTEPH has been reported to be poor when mPAP is > 30 mm Hg.

BPA seems to be a promis- ing strategy for inoperable CTEPH. Reperfusion pul- monary injury is the major complication after BPA. To reduce the size of the area of this complication, it is recommended not to di- late > two vessels at the initial BPA and to perform it in a staged fashion over several separate procedures.

Address for correspondence:

Szymon Darocha, MD, Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, ECZ – Otwock, ul. Borowa 14/18, 05–400 Otwock, Poland, e-mail: szymon.darocha@gmail.com

Conflict of interest: none declared

Figure 1. Left lower segmental PA with occlusion presented in CT scan

Figure 2. Echocardiography of enlarged right atrium and right ventricle

Figure 3. Angiography of narrowed left lower segmental PA before angioplasty

Figure 4. Angiography of left lower seg- mental PA after balloon angioplasty

Cytaty

Powiązane dokumenty

Despite the lack of profound evidence, the treatment of chronic thromboembolic disease is similar to that of patients with pulmonary hypertension: pulmonary endarterectomy is

Initial and refined balloon pulmonary angioplasty (BPA) strategies in patients with chronic thromboembolic pulmonary hypertension recruited to the BPA programme;.. mPAP —

W procesie diagnostycznym powinno się uwzględnić możliwość rozwarstwienia pnia płucnego u pacjentów z przewlekłym nadciśnieniem płucnym, którzy zgłaszają nagły ból w

Methods: A single-centre, non-randomised, follow-up study involved 10 anticoagulated, unoperated patients (3 males and 7 females aged 46 to 77 years) with mild CTEPH (mean

Przewlekłe zakrzepowo-zatorowe nadciśnienie płucne (CTEPH, chronic thromboembolic pulmonary hypertension), kiedyś uważane za rzadkie [1], obecnie rozpoznaje się nawet u 3,8%

Nadciśnienie płucne zakrzepowo-zatorowe (CTEPH, chronic thromboembolic pulmonary hy- pertension) można rozpoznać u pacjenta z odpo- wiednio udokumentowanym przewlekłym zorga-

Angiography and optical coherence tomography (OCT) cross-sections of the eighth segmental branch of the left pulmonary artery, before and after balloon pulmonary angioplasty (BPA)..

Biorąc pod uwagę przebytą zakrzepicę żył głębokich kończyn dol- nych oraz obecność segmentarnych ubytków per- fuzji w scyntygrafii płuc rozpoznano